Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

822
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
822
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

2.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.6K
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

482
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
482
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

1.5K
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
1.5K
Pulmonary Embolism I: Introduction01:19

Pulmonary Embolism I: Introduction

39
A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...
39
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

415
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
415

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neutrophil Extracellular Traps in Patients with Intracerebral Hemorrhage.

Neurocritical care·2026
Same author

Increased Flexibility and Hemocompatibility of NO-Releasing Small Diameter Vascular Grafts in an Ex Vivo Sheep Model.

ACS omega·2026
Same author

Neutrophil extracellular traps offer a new therapeutic target for elephant endotheliotropic herpes virus-hemorrhagic disease (EEHV-HD).

Communications biology·2026
Same author

Combined immunohistochemical and proteomic description of neutrophil extracellular trap burden in acute ischemic stroke thrombi.

Journal of thrombosis and haemostasis : JTH·2026
Same author

Anakinra restores immunological misfiring that drives influenza-associated pulmonary aspergillosis.

Science translational medicine·2025
Same author

Neutrophil extracellular traps and peptidylarginine deiminase 4-mediated inflammasome activation link diabetes to cardiorenal injury and heart failure.

European heart journal·2025
Same journal

Tagraxofusp, Azacitidine, and Venetoclax in Blastic Plasmacytoid Dendritic Cell Neoplasm.

Blood·2026
Same journal

Concurrent administration of BCMA and GPRC5D chimeric antigen receptor (CAR) T cells in advanced multiple myeloma.

Blood·2026
Same journal

Single Cell Analysis of the Tumor Microenvironment Landscape Across the Disease Spectrum of Multiple Myeloma.

Blood·2026
Same journal

Decentralized Clinical Trials in Hematology: the Promise and the Peril.

Blood·2026
Same journal

How I Treat Chemotherapy-Induced Thrombocytopenia with Thrombopoietin Receptor Agonists.

Blood·2026
Same journal

The Chaos of Choice in Large B-cell Lymphoma: A Call to Harmonize First-line Trial Design.

Blood·2026
See all related articles

Related Experiment Video

Updated: May 4, 2026

Author Spotlight: A Novel Method for Comprehensive Cell Component Analysis of Cerebral Blood Clots
06:12

Author Spotlight: A Novel Method for Comprehensive Cell Component Analysis of Cerebral Blood Clots

Published on: July 21, 2023

1.2K

Thrombosis: tangled up in NETs.

Kimberly Martinod1, Denisa D Wagner

  • 1Immunology Graduate Program, Division of Medical Sciences, Harvard Medical School, Boston, MA;

Blood
|December 25, 2013
PubMed
Summary
This summary is machine-generated.

Neutrophil extracellular traps (NETs) are key in blood clot formation. Understanding NETosis offers new therapeutic targets for preventing and treating pathological thrombosis.

More Related Videos

Author Spotlight: Revealing Platelet Dynamics Through Advances in Structural Hematology
05:41

Author Spotlight: Revealing Platelet Dynamics Through Advances in Structural Hematology

Published on: May 24, 2024

853
Ferric Chloride-Induced Arterial Thrombosis and Sample Collection for 3D Electron Microscopy Analysis
03:57

Ferric Chloride-Induced Arterial Thrombosis and Sample Collection for 3D Electron Microscopy Analysis

Published on: March 17, 2023

2.7K

Related Experiment Videos

Last Updated: May 4, 2026

Author Spotlight: A Novel Method for Comprehensive Cell Component Analysis of Cerebral Blood Clots
06:12

Author Spotlight: A Novel Method for Comprehensive Cell Component Analysis of Cerebral Blood Clots

Published on: July 21, 2023

1.2K
Author Spotlight: Revealing Platelet Dynamics Through Advances in Structural Hematology
05:41

Author Spotlight: Revealing Platelet Dynamics Through Advances in Structural Hematology

Published on: May 24, 2024

853
Ferric Chloride-Induced Arterial Thrombosis and Sample Collection for 3D Electron Microscopy Analysis
03:57

Ferric Chloride-Induced Arterial Thrombosis and Sample Collection for 3D Electron Microscopy Analysis

Published on: March 17, 2023

2.7K

Area of Science:

  • Hematology
  • Immunology
  • Molecular Biology

Background:

  • Pathological venous thrombosis involves blood cells, notably platelets and neutrophils.
  • Neutrophil extracellular traps (NETs) have emerged as critical players in thrombus initiation and progression.

Purpose of the Study:

  • To review recent findings on the role of NETs in thrombosis.
  • To explore the biological process of NET formation (NETosis) and its contribution to coagulation and platelet aggregation.

Main Methods:

  • Literature review of recent findings on NETs and thrombosis.
  • Analysis of animal models and genetically engineered mice to study NETosis pathways.
  • Investigation of peptidylarginine deiminase 4's role in NETosis and thrombosis.

Main Results:

  • NETs, through DNA and protein release (histones, serine proteases), promote coagulation and platelet aggregation.
  • Animal models demonstrate NET formation in thrombogenesis.
  • Peptidylarginine deiminase 4 regulates both NETosis and pathological thrombosis.
  • NETs are found in human thrombosis, with plasma biomarkers indicating disease activity.

Conclusions:

  • NETosis is a significant contributor to thrombosis, involving specific molecular pathways.
  • Further characterization of NETosis may lead to novel therapeutic strategies for thrombosis.
  • Potential prophylactic and therapeutic agents targeting NETs are suggested for thrombosis treatment.